GRI Bio to Present at the 8th Annual IPF Summit
GRI Bio, Inc. (GRI)
Company Research
Source: GlobeNewswire
LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Vipin Kumar Chaturvedi, PhD, Chief Scientific Officer of GRI Bio, will present at the 8th Annual IPF Summit taking place August 20-22, 2024 in Boston, MA. Details of the presentation are as follows: Title: Examining the Underlying Mechanism & Patients Subject to the Therapeutic Potential of NK T-Cell TargetingPresenter: Vipin Kumar Chaturvedi, PhD, Chief Scientific Officer of GRI BioSession: Exploring the Clinical Promise of Emerging Modalities & Targets from NK T-Cells to ADCs, Small RNA Inhibitors, Nanotechnology for Fibrosis ControlDate and Time: August 22, 2024, from 8:00-8:30 AM ET For more information about the event, please visit the conference website here. About GRI Bi
Show less
Read more
Impact Snapshot
Event Time:
GRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRI alerts
High impacting GRI Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRI
News
- GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine [Yahoo! Finance]Yahoo! Finance
- GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care MedicineGlobeNewswire
- GRI Bio Announces Closing of $4.0 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- GRI Bio Announces Closing of $4.0 Million Public OfferingGlobeNewswire
- GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators [Yahoo! Finance]Yahoo! Finance
GRI
Sec Filings
- 6/27/24 - Form 424B4
- 6/27/24 - Form 8-K
- 6/27/24 - Form EFFECT
- GRI's page on the SEC website